10/01/2008

Siemens AG, Healthcare Sector

Siemens Introduces New Urinalysis Strip

Siemens Healthcare announces the availability in Europe of a new urinalysis testing product, Clinitek-Microalbumin 9 Urinalysis Strips. These strips provide nine tests to detect and monitor kidney disease across the continuum of patient care. They can be used on Siemens’ Clinitek Status® analyzer or the Clinitek Advantus™ analyzer in a group practice, laboratory or physician office setting.

Identifying diabetic patients with early indications of kidney disease or established kidney disease presents a significant challenge in medicine today. When used on Siemens’ Clinitek analyzers, the new urine strips provide the Albumin to Creatinine (A:C) and Protein to Creatinine (P:C) ratios, adjusted for varying patient urine concentrations to minimize false negative/positive results. This allows for immediate indication of normal or abnormal results.

A:C ratio results are used for early detection of kidney disease in patients with diabetes. Early intervention may stop or reverse the process of kidney disease. The P:C ratio is used to manage patients with kidney disease. The P:C ratio results provided by the Siemens’ Clinitek analyzers meet the needs of clinical specialists managing patients diagnosed kidney disease who are likely to excrete high levels of protein.



The Siemens Healthcare Sector is one of the world’s largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first integrated healthcare company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care – from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens Healthcare is the global market leader in innovative hearing instruments. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of €9.85 billion, orders of €10.27 billion, and group profit of €1.32 billion. Further information can be found by visiting www.siemens.com/healthcare